Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors

Published:2019-10-14 Issue:12 Volume:110 Page:3821-3833
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Ohshima Keiichi¹²^ORCID,Fujiya Keiichi³,Nagashima Takeshi⁴⁵^ORCID,Ohnami Sumiko⁴,Hatakeyama Keiichi¹^ORCID,Urakami Kenichi⁴⁶,Naruoka Akane²^ORCID,Watanabe Yuko¹,Moromizato Sachi¹,Shimoda Yuji⁴⁵,Ohnami Shumpei⁴,Serizawa Masakuni²,Akiyama Yasuto⁷,Kusuhara Masatoshi²⁶,Mochizuki Tohru¹,Sugino Takashi⁸,Shiomi Akio⁹,Tsubosa Yasuhiro¹⁰,Uesaka Katsuhiko¹¹,Terashima Masanori³,Yamaguchi Ken¹²

Affiliation:

1. Medical Genetics Division Shizuoka Cancer Center Research Institute Shizuoka Japan

2. Drug Discovery and Development Division Shizuoka Cancer Center Research Institute Shizuoka Japan

3. Division of Gastric Surgery Shizuoka Cancer Center Hospital Shizuoka Japan

4. Cancer Diagnostics Research Division Shizuoka Cancer Center Research Institute Shizuoka Japan

5. SRL, Inc. Tokyo Japan

6. Region Resources Division Shizuoka Cancer Center Research Institute Shizuoka Japan

7. Immunotherapy Division Shizuoka Cancer Center Research Institute Shizuoka Japan

8. Division of Pathology Shizuoka Cancer Center Hospital Shizuoka Japan

9. Division of Colon and Rectal Surgery Shizuoka Cancer Center Hospital Shizuoka Japan

10. Division of Esophageal Surgery Shizuoka Cancer Center Hospital Shizuoka Japan

11. Division of Hepato‐Biliary‐Pancreatic Surgery Shizuoka Cancer Center Hospital Shizuoka Japan

12. Shizuoka Cancer Center Hospital and Research Institute Shizuoka Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14202

Reference55 articles.

1. Gastrointestinal stromal tumor;Zhao X;J Gastrointest Oncol,2012

2. Gastrointestinal stromal tumours: origin and molecular oncology

3. Gastrointestinal stromal tumour

4. Risk stratification of patients diagnosed with gastrointestinal stromal tumor

5. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of heterozygosity in gastric cancers in a set of Mexican patients;2024-07-29

2. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis;Annals of Nuclear Medicine;2024-01-13

3. Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential;Molecular Oncology;2023-09-03

4. Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis;Cell Death & Disease;2023-07-06

5. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors HarboringKITExon 11 557–558 Deletion Mutations;Cancer Research Communications;2023-04-24